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Gene-expression during fat-cell development<p>In-depth bioinformatics analyses of expressed sequence tags found to be differentially expressed during differentiation of 3T3-L1 pre-adipocyt  cells were combined with de novo functional annotation and mapping onto known athways to generate a molecular atlas of fatcell development.</p>
Abstract
Background: Large-scale transcription profiling of cell models and model organisms can identify
novel molecular components involved in fat cell development. Detailed characterization of the
sequences of identified gene products has not been done and global mechanisms have not been
investigated. We evaluated the extent to which molecular processes can be revealed by expression
profiling and functional annotation of genes that are differentially expressed during fat cell
development.
Results: Mouse microarrays with more than 27,000 elements were developed, and transcriptional
profiles of 3T3-L1 cells (pre-adipocyte cells) were monitored during differentiation. In total, 780
differentially expressed expressed sequence tags (ESTs) were subjected to in-depth bioinformatics
analyses. The analysis of 3'-untranslated region sequences from 395 ESTs showed that 71% of the
differentially expressed genes could be regulated by microRNAs. A molecular atlas of fat cell
development was then constructed by de novo functional annotation on a sequence segment/
domain-wise basis of 659 protein sequences, and subsequent mapping onto known pathways,
possible cellular roles, and subcellular localizations. Key enzymes in 27 out of 36 investigated
metabolic pathways were regulated at the transcriptional level, typically at the rate-limiting steps in
these pathways. Also, coexpressed genes rarely shared consensus transcription-factor binding
sites, and were typically not clustered in adjacent chromosomal regions, but were instead widely
dispersed throughout the genome.
Conclusions: Large-scale transcription profiling in conjunction with sophisticated bioinformatics
analyses can provide not only a list of novel players in a particular setting but also a global view on
biological processes and molecular networks.
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Obesity, the excess deposition of adipose tissue, is among the
most pressing health problems both in the Western world and
in developing countries. Growth of adipose tissue is the result
of the development of new fat cells from precursor cells. This
process of fat cell development, known as adipogenesis, leads
to the accumulation of lipids and an increase in the number
and size of fat cells. Adipogenesis has been extensively stud-
ied in vitro for more than 30 years using the 3T3-L1 preadi-
pocyte cell line as a model. This cell line was derived from
disaggregated mouse embryos and selected based on the pro-
pensity of these cells to differentiate into adipocytes in culture
[1]. When exposed to the appropriate adipogenic cocktail con-
taining dexamethasone, isobutylmethylxanthine, insulin, and
fetal bovine serum, 3T3-L1 preadipocytes differentiate into
adipocytes [2].
Experimental studies on adipogenesis have revealed many
important molecular mechanisms. For example, two of the
CCAAT/enhancer binding proteins (C/EBPs; specifically C/
EBPβ and C/EBPδ) are induced in the early phase of differen-
tiation. These factors mediate transcriptional activity of C/
EBPα and peroxisome proliferator-activated receptor
(PPAR)-gamma (PPARγ) [3,4]. Another factor, the basic
helix-loop-helix (bHLH) transcription factor adipocyte deter-
mination and differentiation dependent factor 1/sterol regu-
latory element binding protein 1 (ADD1/SREBP1c), could
potentially be involved in a mechanism that links lipogenesis
and adipogenesis. ADD1/SREBP1c can activate a broad pro-
gram of genes that are involved in fatty acid and triglyceride
metabolism in both fat and liver, and can also accelerate adi-
pogenesis [5]. Activation of the adipogenesis process by
ADD1/SREBP1c could be effected via direct activation of
PPARγ [6] or through generation of endogenous ligands for
PPARγ [7].
Knowledge of the transcriptional network is far from com-
plete. In order to identify new components involved in fat cell
development, several studies using microarrays have been
initiated. These studies have used early Affymetrix technol-
ogy [8-14] or filters [15], and might have missed many genes
that are important to the development of a fat cell. The prob-
lem of achieving broad coverage of the developmental tran-
scriptome became evident in a mouse embryo expressed
sequence tag (EST) project, which revealed that a significant
fraction of the genes are not represented in the collections of
genes previously available [16]. Moreover, earlier studies on
adipogenesis [8-14] focused on gene discovery for further
functional analyses and did not address global mechanisms.
We conducted the present study to evaluate the extent to
which molecular processes underlying fat cell development
can be revealed by expression profiling. To this end, we used
a recently developed cDNA microarray with 27,648 ESTs [17],
of which 15,000 are developmental ESTs representing 78%
novel and 22% known genes [18]. We then assayed expression
profiles from 3T3-L1 cells during differentiation using biolog-
ical and technical replicates. Finally, we performed compre-
hensive bioinformatics analyses, including de novo
functional annotation and curation of the generated data
within the context of biological pathways. Using these meth-
ods we were able to develop a molecular atlas of fat cell devel-
opment. We demonstrate the power of the atlas by
highlighting selected genes and molecular processes. With
this comprehensive approach, we show that key loci of tran-
scriptional regulation are often enzymes that control the rate-
limiting steps of metabolic pathways, and that coexpressed
genes often do not share consensus promoter sequences or
adjacent locations on the chromosome.
Results
Expression profiles during adipocyte differentiation
The 3T3-L1 cell line treated with a differentiation cocktail was
used as a model to study gene expression profiles during adi-
pogenesis. Three independent time series differentiation
experiments were performed. RNA was isolated at the pre-
confluent stage (reference) and at eight time points after con-
fluence (0, 6, 12, 24, 48 and 72 hours, and 7 and 14 days).
Gene expression levels relative to the preconfluent state were
determined using custom-designed microarrays with spotted
polymerase chain reaction (PCR) products. The microarray
developed here contains 27,648 spots with mouse cDNA
clones representing 16,016 different genes (UniGene clus-
ters). These include 15,000 developmental clones (the NIA
cDNA clone set from the US National Institute of Aging of the
National Institutes of Health NIH), 11,000 clones from differ-
ent brain regions in the mouse (Brain Molecular Anatomy
Project [BMAP]), and 627 clones for genes which were
selected using the TIGR Mouse Gene Index, Build 5.0 [19].
All hybridizations were repeated with reversed dye assign-
ment. The data were filtered, normalized, and averaged over
biological replicates. Data processing and normalization are
described in detail under Materials and methods (see below).
Signals at all time points could be detected from 14,368 ele-
ments. From these microarray data, we identified 5205 ESTs
that exhibited significant differential expression between
time points and had a complete profile (P < 0.05, one-way
analysis of variance [ANOVA]). Because ANOVA filters out
ESTs with flat expression profiles, we used a fold change cri-
teria to select the ESTs for further analysis. We focused on
780 ESTs that had a complete profile over all time points, and
that were more than twofold upregulated or downregulated in
at least four of those time points. These stringent criteria were
necessary to select a subset of the ESTs for in-depth sequence
analysis and for examination of the dynamics of the molecu-
lar processes. The overlap between the ANOVA and twofold
filtered ESTs was 414. All of the data, together with annota-
tions and other files used in the analyses, are available as
Additional data files and on our website [20]. The analysesGenome Biology 2005, 6:R108
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780 ESTs.
Validation of expression data
Four lines of evidence support the quality of our data and its
consistency with existing knowledge of fat cell biology. First,
our array data are consistent with reverse transcriptase (RT)-
PCR analysis. We compared the microarray data with quanti-
tative RT-PCR for six different genes (Pparg [number 592,
cluster 6], Lpl [number 14, cluster 6], Myc [number 224, clus-
ter 11], Dcn [number 137, cluster 7], Ccna2 [number 26, clus-
ter 5/8], and Klf9 [number 6, cluster 9]) at different time
points (Additional data file 9 and on our website [20]). A high
degree of correlation was found (r2 = 0.87), confirming the
validity of the microarray data.
Second, statistical analyses of the independent experiments
showed that the reproducibility of the generated data is very
high. The Pearson correlation coefficient between the repli-
cates was between 0.73 and 0.97 at different time points. The
mean coefficient of variation across all genes at each time
point was between 0.11 and 0.27. The row data and the details
of the statistical analyses can be found in Additional data file
10 and on our website [20].
Third, comparison between our data and the Gene Atlas V2
mouse data for adipose tissue [21] shows that the consistency
of the two data sets increases with differentiation state (Addi-
tional data files 11 and 12, and our on website [20]). There-
fore, this analysis supports the relevance of the chosen cell
model to in vivo adipogenesis. Among the 382 transcription-
ally modulated genes common in both data sets, 67% are reg-
ulated in the same direction at time point zero (confluent pre-
adipocyte cell culture). At the final stage of differentiation, the
correlation increases up to 72%. If the Gene Atlas expression
data are restricted to strongly regulated genes (at least two-
fold and fourfold change respectively), then the consistency
in mature adipocytes rises to 82% (135 genes) and 93% (42
genes), respectively. Out of all 60 tissues in the Gene Atlas V2
mouse, the adipose tissue describes the differentiated state of
the 3T3-L1 cells best. Brown fat tissue is the second best
match to the differentiated adipocytes (69% of the 382
genes), followed by adrenal gland (66%), kidney (65%), and
heart (64%). At each time point in which cell cycle genes were
not repressed (12 hours and 24 hours), all tissues had similar
correlation to the data set (44-55% for 382 genes).
The fourth line of evidence supporting the quality of our data
is that there is clear correspondence between our data and a
previously published data set [8]. For a group of 153 genes
shared among the two studies, the same upregulation or
downregulation was found for 72-89% (depending on time
point) of all genes (see Additional data file 13 and our website
[20]). The highest identity (89%) was found for the stage ter-
minally differentiated 3T3-L1 cells, for which the profile is
less dependent on the precise extraction time. If the compar-
ison is restricted to expression values that are strongly regu-
lated in both experiments (at least twofold change at day 14,
96 ESTs), then the coincidence at every time point is greater
than 90%. Comparisons with this [8] and two additional data
sets [9,12], and the data pre-processing steps are given in
Additional data files 13, 14, 15 and on our website [20]. Note
that, because of the differences in the used microarray plat-
forms, availability of the data, normalization methods, and
annotations, only 96 genes are shared between all four stud-
ies. Of the 780 ESTs monitored in our work, 326 were not
detected in the previous studies [8,9,12]: 106 RefSeqs (with
prefix NM), 43 automatically generated RefSeqs (with prefix
XM), and 173 ESTs (Additional data file 16). 
Correspondence between transcriptional coexpression 
and gene function
To examine the relationships between coexpression and gene
functions, we first clustered 780 ESTs that were twofold dif-
ferentially expressed into 12 temporally distinct patterns,
containing between 23 and 143 ESTs (Figure 1). ESTs in four
of the clusters are mostly upregulated during adipogenesis,
whereas genes in the other eight clusters are mostly
downregulated.
We then categorized ESTs with available RefSeq annotation
and Gene Ontology (GO) term (486 out of 780) for molecular
function, cellular component, and biological process (Figure
2). Genes in clusters 5 and 8 are downregulated through the
whole differentiation process and upregulated at 12/24
hours. Many of the proteins encoded by these genes are
involved in cell cycle processes and were residing in the
nucleus (Figure 2). Re-entry into the cell cycle of growth
arrested pre-adipocytes is known as the clonal expansion
phase and considered to be a prerequisite for terminal differ-
entiation in 3T3-L1 adipocytes [22]. Genes grouped in cluster
2 are highly expressed from 6 hours (onset of clonal expan-
sion) to 3 days (start of the appearance of adipocyte morphol-
ogy) but are only modestly expressed at the terminal
adipocyte differentiation stage. These include a number of
genes that encode signaling molecules. Genes increasingly
expressed toward the terminal differentiation stage are in
clusters 4, 6, and 7, although from different starting values.
Clustering of ESTs found to be differentially expressed during fat cell differentiationFigure 1 (see previous page)
Clustering of ESTs found to be differentially expressed during fat cell differentiation. Shown is k-means clustering of 780 ESTs found to be more than 
twofold upregulated or downregulated at a minimum of four time points during fat cell differentiation. ESTs were grouped into 12 clusters with distinct 
expression profiles. Relative expression levels (log2 ratios) for EST gene at different time points are shown and color coded according to the legend at the 
top (left) and expression profile (mean ± standard deviation) for each cluster (right). EST, expressed sequence tag.Genome Biology 2005, 6:R108
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lism and mitochondrial fatty acid metabolism, whereas some
genes can be associated with cholesterol biosynthesis and
related to extracellular space or matrix in clusters 4 and 7,
respectively.
Correspondence between coexpression and targeting 
by microRNAs
Previous studies suggest that protein production for 10% or
more of all human and mouse genes are regulated by microR-
NAs (miRNAs) [23,24]. miRNAs are short, noncoding, single-
strand RNA species that are found in a wide variety of organ-
isms. miRNAs cause the translational repression or cleavage
of target messages [25]. Some miRNAs may behave like small
interfering RNAs. It appears that the extent of base pairing
between the small RNA and the mRNA determines the bal-
ance between cleavage and degradation [26]. Rules for
matches between miRNA and target messages have been
deduced from a range of experiments [24] and applied to the
prediction and discovery of mammalian miRNA targets
[23,27]. Moreover, it was shown that human miRNA-143 is
involved in adipocyte differentiation [28].
Here we conducted an analysis to determine which of the 780
ESTs differentially expressed during adipocyte differentia-
tion were potential targets of miRNAs and whether there is an
over-representation of miRNA targets of coexpressed ESTs
clustered in 12 distinct expression patterns. From the 780
ESTs, the 3'-untranslated region (UTR) could be derived for
539. Of these, 518 had at least one exact antisense match for
Distribution of GO terms for genes/ESTs in each clusterFigure 2
Distribution of GO terms for genes/ESTs in each cluster. The GO terms listed here are those present in at least 15% of the genes within the cluster. In 
brackets are the number of genes/ESTs with associated GO terms and the number of genes/ESTs within the cluster. EST, expressed sequence tag; GO, 
Gene Ontology.
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from the 234 miRNA sequences (18-24 base pairs [bp];
Additional data file 14). From 395 ESTs with a unique 3'-UTR,
282 (71%) had at least one match over-represented compared
with the whole 3'-UTR sequence set (21,396; P < 0.05, by one-
sided Fisher's exact test). The distribution of statistically
over-represented miRNA motifs in 3'-UTRs across the clus-
ters was variable, with genes grouped in cluster 9 (including
many transcriptional regulators) having the most statistically
over-represented miRNA motifs and genes in cluster 5 having
no detectable motifs (Additional data file 18). The results of
the analysis of cluster 9 are given in Figure 3. One of the genes
with the most significantly over-represented miRNA motifs
in the 3'-UTR is related to the ras family (Figure 3). It was pre-
viously shown that human oncogene RAS is regulated by let-
7 miRNA [29]. Further potential miRNA target genes from all
clusters are given in Additional data files 9, 18, 19, 20, 21, 22,
23, 24, 25, 26, 27, 28, 29, 30.
Molecular atlas of fat cell development derived by de 
novo functional annotation of differentially expressed 
ESTs
In order to functionally characterize the molecular compo-
nents underlying adipogenesis in detail, comprehensive bio-
informatics analyses of 780 differentially expressed ESTs
were performed. A total of 659 protein sequences could be
derived, and these were subjected to in-depth sequence ana-
lytic procedures. The protein sequences have been annotated
de novo using 40 academic prediction tools integrated in the
ANNOTATOR sequence analysis system. The structure and
Genes in cluster 9 and significantly over-represented miRNA motifs (blue squares)Figure 3
Genes in cluster 9 and significantly over-represented miRNA motifs (blue squares). miRNA, microRNA.
NM_178935 CXORF15 (4932441K18)
NM_011058 platelet derived growth factor receptor, alpha polypeptide (Pdgfra)
NM_010763 mannosidase 1, beta (Man1b)
NM_173781 RAB6B, member RAS oncogene family (Rab6b)
NM_172537 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (Sema6d)
NM_010284 growth hormone receptor (Ghr)
NM_173371 hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (H6pd)
NM_020591 RIKEN cDNA A030009H04 gene (A030009H04Rik)
NM_148938 solute carrier family 1 (glial high affinity glutamate transporter), member 3 (Slc1a3)
NM_080454 gap junction membrane channel protein alpha 12 (Gja12)
NM_013758 adducin 3 (gamma) (Add3)
NM_008047 follistatin-like 1 (Fstl1)
NM_023719 thioredoxin interacting protein (Txnip)
NM_019814 hypoxia induced gene 1 (Hig1)
NM_001001881 RIKEN cDNA 2510009E07 gene (2510009E07Rik)
NM_010638 basic transcription element binding protein 1 (Bteb1)
NM_011204 protein tyrosine phosphatase, non-receptor type 13 (Ptpn13)
NM_010160 CUG triplet repeat,RNA binding protein 2 (Cugbp2)
NM_080555 phosphatidic acid phosphatase type 2B (Ppap2b)
XM_181333 PREDICTED: RIKEN cDNA 1300001I01 gene (1300001I01Rik)
NM_013587 low density lipoprotein receptor-related protein associated protein 1 (Lrpap1)
NM_133792 lysophospholipase 3 (Lypla3)
NM_173440 nuclear receptor interacting protein 1 (Nrip1)
NM_009572 zinc fingers and homeoboxes protein 1 (Zhx1)
NM_010884 N-myc downstream regulated gene 1 (Ndrg1)
NM_011055 phosphodiesterase 3B, cGMP-inhibited (Pde3b)
NM_009949 carnitine palmitoyltransferase 2 (Cpt2)
NM_019739 forkhead box O1 (Foxo1)
NM_153537 pleckstrin homology-like domain, family B, member 1 (Phldb1)
NM_010097 SPARC-like 1 (mast9, hevin) (Sparcl1)
NM_011594 tissue inhibitor of metalloproteinase 2 (Timp2)
XM_358343 PREDICTED: sulfatase 2 (Sulf2)
NM_022415 prostaglandin E synthase (Ptges)
NM_054071 fibroblast growth factor receptor-like 1 (Fgfrl1)
NM_177870 solute carrier family 5 (sodium-dependent vitamin transporter), member 6 (Slc5a6)
NM_144938 complement component 1, s subcomponent (C1s)
NM_011658 twist gene homolog 1 (Drosophila) (Twist1)
NM_013842 X-box binding protein 1 (Xbp1)
NM_021524 pre-B-cell colony-enhancing factor 1 (Pbef1)
NM_016895 adenylate kinase 2 (Ak2)
NM_019831 zinc finger protein 261 (Zfp261)
NM_026728 DNA segment, Chr 4, ERATO Doi 765, expressed (D4Ertd765e)
NM_007569 B-cell translocation gene 1, anti-proliferative (Btg1)
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NM_028865 RIKEN cDNA 1110005A03 gene (1110005A03Rik)
NM_080635 eukaryotic translation initiation factor 3, subunit 3 (gamma) (Eif3s3)
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nfunction was annotated on a sequence segment/domain-wise
basis. After extensive literature search and curation using the
sequence architecture, 345 gene products were mapped onto
known pathways, possible cellular roles, and subcellular
localizations (Figure 4) using the PathwayExplorer web serv-
ice [30] as well as manual literature and domain-based
assignment. The results of the sequence analyses and addi-
tional information is available in the supplementary material
available on our website [20] and Additional data files 6, 7, 8.
This molecular atlas of fat cell development provides the first
global view of the underlying biomolecular networks and rep-
resents a unique resource for deriving testable hypotheses for
future studies on individual genes. Below we demonstrate the
usefulness of the atlas by highlighting the following: estab-
lished regulators of fat cell development, recently discovered
fat cell gene products, and candidate transcription factors
expressed during adipogenesis. The numbering of the genes
is given according to the de novo functional annotation (Addi-
tional data file 7).
Established regulators of fat cell development
Key transcription factors SREBF1 (Srebf1 [number 119, clus-
ter 9]) and PPARγ (Pparg [number 592, cluster 6]) were
highly expressed during the late phase of differentiation.
PPARγ [31] (Pparg [number 592, cluster 6]) is increasing up
to about 15-fold. Srebf1 processing is inhibited by insulin-
induced gene 1 (Insig1 [number 62, cluster 3/4]) through
binding of the SREBP cleavage-activation protein [32,33].
Insig1 is regulated by Srebf1 and Pparg at the transcriptional
level [34] and the expression of known marker genes of the
differentiated adipocyte was increased in parallel with these
factors. These include genes from clusters 3, 6, and 9 that are
targets of either of these factors: lipoprotein lipase (Lpl
[number 14, cluster 6]), c-Cbl-associated protein (Sorbs1
[number 92, cluster 6]), stearoyl-CoA desaturase 1 (Scd1
[number 305, cluster 6]), carnitine palmitoyltransferase II
(Cpt2 [number 43, cluster 9]), and acyl-CoA dehydrogenase
(Acadm [number 153, clusters 6 and 9]).
Recently discovered fat cell gene products
During the preparation of the manuscript, a number of fac-
tors shown to be important to adipocyte function were identi-
fied in vivo. All of these factors, which have a possible role in
the pathogenesis of obesity and insulin resistance, were
highly expressed in the present study. Adipose triglyceride
lipase (Pnpla2 [number 157, cluster 6]), a patatin domain-
containing triglyceride lipase that catalyzes the initial step in
triglyceride hydrolysis [35], was more than 20-fold upregu-
lated at the terminal differentiation phase. Another example
is Visfatin, which is identical to the pre-B cell colony-enhanc-
ing factor (Pbef [number 327, cluster 9]). This 52 kDa
cytokine has enzymatic function in adipocytes, exerts insulin-
mimetic effects in cultured cells, and lowers plasma glucose
levels in mice by binding to the insulin receptor [36-38]. The
imprinted gene mesoderm-specific transcript (Mest [number
17, cluster 6/9]), which appears to enlarge adipocytes and
could be a novel marker of the size of adipocytes [12], is
upregulated during the late stage of 3T3-L1 differentiation.
Members of the Krüppel-like factor (Klf) family, also known
as basic transcription element binding proteins, are relevant
within the context of adipocyte differentiation. Klf2 was
shown to inhibit PPARγ expression and to be a negative regu-
lator of adipocyte differentiation [39]; Klf5 [40], Klf6 [41],
and Klf15 [42] have been demonstrated to induce adipocyte
differentiation. Whereas Klf9 (Bteb1 [number 6, cluster 9])
was upregulated in the intermediate phase in the present
study, Klf4 (number 100, cluster 12), which was shown to
exert effects on cell proliferation opposing those of Klf5 [43],
was downregulated. Another twofold upregulated player is
Forkhead box O1 (Foxo1 [number 53, cluster 9]), which
mediates effects of insulin on the cell. Activation occurs
before the onset of terminal differentiation, when Foxo1
becomes dephosphorylated and localizes to the nucleus
[44,45]. The glucocorticoid-induced leucine zipper
(Tsc22d3/Gilz [number 173, cluster 2]) functions as a tran-
scriptional repressor of PPARγ and can antagonize glucocor-
ticoid-induced adipogenesis [46,47]. This is consistent with
our observation that Gilz is highly upregulated during the
first two days, when dexamethasone is present in the
medium, and downregulated at the end of differentiation,
when PPARγ is highly induced. C/EBP homologous protein
10 (Ddit3 [number 498, cluster 3]), another type of transcrip-
tional repressor that forms nonfunctional heterodimers with
members of the C/EBP family, was early induced and then
downregulated. This might be sufficient to restore the tran-
scriptional activity of C/EBPβ and C/EBPδ [42]. The tran-
scription factor insulinoma-associated 1 (Insm1 [number
238, cluster 8]) is associated with differentiation into insulin-
positive cells and is expressed during embryo development,
where it can bind the PPARγ target Cbl-associated protein
(Sorbs1 [number 92, cluster 6]; upregulated after induction)
[48,49].
Candidate transcription factors expressed during adipogenesis
Because knowledge of the transcriptional network during adi-
pogenesis is far from complete, expression profiles have been
generated and screened for candidate transcription factors
[8,9,12]. Here, we identified a number of transcription factors
Cellular localization of gene productsFigure 4 (see foll wing pag )
Cellular localization of gene products. Shown are the cellular localizations of gene products involved in (a) metabolism and (b) other biological processes 
during fat cell differentiation. Gene products are color coded for each of the 12 clusters (key given to the left of the figure). The numbering is given 
according to the de novo functional annotation (Additional data files 6, 7, 8).Genome Biology 2005, 6:R108
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nthe exhibit distinct kinetic profiles during adipocyte
differentiation that were previously not functionally associ-
ated with adipogenesis. Two transcription factors were
unique to the present study (Zhx3 and Zfp367), and three
more were confirmed (Zhx1, Twist1 and Tcf19) and annotated
in the pathway context.
We found evidence for a role of the zinc finger and homeobox
protein 3 (Zhx3 [number 306, cluster 2]). Zhx3 as well as Zinc
finger and homeobox protein 1 (Zhx1 [number 386, cluster
9]) might attach to nuclear factor Y, which in turn binds many
CCAAT and Y-box elements [50]. We also provide data
regarding the expression of zinc finger protein 367 (Zfp367
[number 320, cluster 8]) during adipogenesis. The molecular
function of Zfp367 is as yet uncharacterized.
Additionally, we provide further experimental evidence and
pathway context for candidate transcription factors previ-
ously identified in microarray screens [9,12], namely Twist1
and Tcf19. The Twist gene homolog 1 (Twist1 [number 235,
cluster 9]) was about two- to threefold upregulated at 0 hours,
72 hours, 7 days, and 14 days. Twist1 is a reversible inhibitor
of muscle differentiation [51]. Heterozygous double mutants
(Twist1-/+, Twist2-/+) exhibit loss of subcutaneous adipose
tissue and severe fat deficiency in internal organs [52]. Twist1
is a downstream target of nuclear factor-κB and can repress
transcription of tumor necrosis factor-α, which is a potent
repressor of adipogenesis [52,53]. The differential expression
during adipogenesis of Tcf19 was also confirmed in the
present study. Tcf19 is a transcription regulator that is
involved in cell cycle processes at later stages in cell cycle pro-
gression [54]. Expression of other regulators that are involved
in the same process support this observation. Forkhead box
M1 (Foxm1 [number 194, cluster 8]) stimulates the expres-
sion of cell cycle genes (for instance the genes encoding cyclin
B1 and cyclin B2, and Cdc25B and Cdk1). In addition, TAF10
RNA polymerase II, also known as TATA box binding protein-
associated factor (Taf10 [number 518, cluster 8]), is involved
in G1/S progression and cyclin E expression [55].
Correspondence between phenotypic changes and 
gene expression
In addition to the metabolic networks, the molecular atlas
also provides a bird's eye view of other molecular processes,
including signaling, the cell cycle, remodeling of the extracel-
lular matrix, and cytoskeletal changes. Changes that occur
during adipogenesis (phenotypically seen as rounding of
densely packed cells) have aspects in common with other tis-
sue differentiation processes such as endothelial angiogenesis
(protease, collagen, and noncollagen molecule secretion) [56]
and specific features. Here we show that phenotypic changes
that occur in maturing adipocytes are paralleled by expres-
sion of the respective genes.
Extracellular matrix remodeling
Matrix metalloproteinase-2 (MMP-2 [number 342, cluster
2]) was strongly upregulated during the entire process of adi-
pocyte differentiation. Matrix metalloproteinase-2 can cleave
various collagen structures and its inhibition can block adipo-
genesis [57]. Tissue inhibitor of metalloproteinase-2 (Timp2
[number 239, cluster 9]), a known partner of matrix metallo-
proteinase-2, which balances the activity of the proprotease/
protease [58], was mainly upregulated. Decreased levels of
tissue inhibitor of metalloproteinase-3 (number 81, cluster
10; upregulated at 6 hours and repressed after 12 hours) are
associated with obese mice [59]. New collagen structures of
overexpressed Col6a2 (number 11, cluster 9), Col4a1
(number 58, cluster 2) and Col4a2 (number 303, cluster 2)
[60] are cross-linked by the lysyl oxidase (Lox [number 282,
cluster 2]; upregulated during adipogenesis, which is con-
trary to findings reported by Dimaculangan and coworkers
[61]). Strongly upregulated decorin (Dcn [number 137/623,
cluster 7]) and osteoblast specific factor 2 (Postn/Osf-2
[number 183, cluster 7]), as well as proline arginine-rich end
leucine-rich repeats (Prelp [number 73/484, cluster 3];
upregulated in the final stages of adipogenesis), attach the
matrix to the cell. Matrillin-2 (Matn2 [number 12, cluster 9];
upregulated during adipogenesis) functions as adaptor for
noncollagen structures [62], as does nidogen 2 (Nid2
[number 294, clusters 6 and 9]; increasingly upregulated).
Secreted protein acidic and rich in cysteine/osteonectin
(SPARC [number 67, cluster 9]; mainly upregulated) and
SPARC-like 1 (Sparcl1 [number 154, cluster 9]; upregulated
at 0 hours, 72 hours, 7days, and 14 days) can organize extra-
cellular matrix remodeling, inhibit cell cycle progression, and
induce cell rounding in cultured cells [63,64].
Reorganization of the cytoskeleton
Most cytoskeletal proteins are coexpressed in cluster 10 (not
repressed from 6 to 12 hours) and might have a common reg-
ulatory mechanism. Transcription of actin α (Acta1 [number
445, cluster 10]) and actin γ (Actg1 [number 656, cluster 10]),
tubulin α (Tuba4 [number 377, cluster 8]), and tubulin β
(Tubb5 [number 110, cluster 8]) were found to diminish dur-
ing differentiation, which is in agreement with other reports
[65]. Myosin light chain 2 (Mylc2b/Mylpf [number 87/88/
52/421, cluster 10]), and tropomyosin 1 and 2 (Tpm1/Tpm2
[number 74/68, cluster 10]) are members of the mainly
repressed cluster 10. The downregulated transgelin 1 and 2
(Tagln/Tagln2 [number 114/242, cluster 10/8]) as well as
fascin homolog 1 (Fscn1 [number 30, cluster 10]) are known
actin-bundling proteins [66,67]. Apparently, their absence
decreases the cross-linking of microfilaments in compact par-
allel bundles. Calponin 2 (Cnn2 [number 7, cluster 10]), a reg-
ulator of cytokinesis, is downregulated [68]. The insulin
receptor and actin binding proteins filamin α and β (Flna/
Flnb [number 506/632, cluster 10]) can selectively inhibit the
mitogen-activated protein kinase signaling cascade of the
insulin receptor [69]. Finally, the maintenance protein
ankycorbin (Rai14 [number 59, cluster 10]) and the cross-Genome Biology 2005, 6:R108
R108.10 Genome Biology 2005,     Volume 6, Issue 13, Article R108       Hackl et al. http://genomebiology.com/2005/6/13/R108linking protein actinin 1 (Actn1 [number 521, cluster 10])
share the mainly repressed expression profile. Tubulin γ 1
(Tubg1 [number 78, cluster 7]; upregulated during
adipogenesis, about 42-fold at 6 hours) is not a component of
the microtubules like Tuba/Tubb, but it plays a role in organ-
izing their assembly and in establishing cell polarity [70].
Actinin 4 (Actn4 [number 185, cluster 9]; upregulated
throughout adipogenesis) differs from Actn1 in its localiza-
tion. Its expression leads to higher cell motility, and it can be
translocated into the nucleus upon phosphatidylinositol 3-
kinase inhibition [71]. Adducin 3γ (Add3 [number 50, cluster
9]; permanently upregulated) has different actin-associated
cytoskeletal roles.
Table 1
Activated metabolic pathways during adipocyte differentiation and their key enzymes (rate limiting steps)
Pathway Enzyme/Protein name Accession number Number Cluster
Urea cycle and arginine-citrulline cycles Arginine succinate synthase NP_031520 128 1/10
Phosphatidylinositol Phosphatidylinositol 3-kinase, regulatory subunit, 
polypeptide 1
XP_127550 446 7
Myoinositol 1-phosphate synthase A1 NP_076116 156 8
Cholesterol biosynthesis/keto-body synthesis 3-hydroxy-3-methylglutaryl-CoA synthase 1 NP_666054 178 4
3-hydroxy-3-methylglutaryl-CoA reductase XP_127496 619 12
Triglyceride hydrolysis (fatty acid assimilation) Lipoprotein lipase (LPL) NP_032535 14 6
β-Oxidation Acetyl-CoA dehydrogenase (Acad) NP_780533 61 6
Acetyl-CoA dehydrogenase, medium chain 
(Acadm)
NP_031408 153 6/9
Isovaleryl-CoA dehydrogenase (Acad) Mm.6635 510 6
Acyl-CoA dehydrogenase, short/branched chain 
(Acadsb)
NP_080102 220 9
Triglyceride metabolism Adipose triglyceride lipase (Pnpla2/Atgl) NP_080078 157 6
CoA biosynthesis Pantothenate kinase 3 NP_666074 140 6
Anaplerotic processes Pyruvate carboxylase NP_032823 149 6
Branched chain amino acid metabolism (AKA 
metabolism)
Branched chain ketoacid dehydrogenase E1, α 
polypeptide
NP_031559 193 3/9
Methylation S-adenosylhomocysteine hydrolase NP_057870 66 8
Methionine adenosyltransferase II, α NP_663544 350 2
Unsaturated fatty acid biosynthesis Stearoyl-CoA desaturase 1 NP_033153 305 6
Nucleotide metabolism Xanthine dehydrogenase NP_035853 361 2
Taurin biosynthesis Cysteine dioxygenase NP_149026 271 7
NH4+ metabolism/glutamate Glutamate-ammonia ligase (glutamine synthase) NP_032157 318 7
Glycolysis Pyruvate kinase 3 NP_035229 247 8
Substrate cycle (glycolysis/gluconeogenesis) Fructose bisphosphatase 2 NP_032020 175 9
Nucleotide biosynthesis Deoxycytidine kinase NP_031858 363 8
Ribonucleotide reductase M2 NP_033130 448 8
Pentose phophate shunt Hexose-6-phosphate dehydrogenase (AI785303) XP_181411 533 9
NAD(P) biosynthesis Pre-B-cell colony-enhancing factor NP_067499 327 9
Polyamine biosynthesis Ornithine decarboxylase, structural NP_038642 212 10
Tetrahydrobiopterin biosynthesis GTP cyclohydrolase 1 NP_032128 259 10
Purin biosynthesis Phosphoribosyl pyrophosphate amidotransferase NP_742158 287 11
Asparagine biosynthesis Asparagine synthetase NP_036185 109 12
Long chain fatty acids ELOVL family member 6, elongation of long chain 
fatty acids
NP_569717 162 12
Serine biosynthesis Phosphoserine phosphatase NP_598661 261 12
Gluconeogenesis PEPCK 2 (Riken 9130022B02) NP_083270 393 12
Prostaglandin E biosynthesis Prostaglandin E synthase (ri|2410099E23; 
ri|9230102G02)
ri|2410099E23
ri|9230102G02
539
540
9
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nT-lymphoma invasion and metastasis 1 (Tiam1 [number 159,
cluster 2]) is a guanine nucleotide exchange factor of the
small GTPase Rac1, which regulates actin cytoskeleton, mor-
phology and adhesion, and antagonizes RhoA signaling
[72,73]. Additionally, the putative constitutive active Rho
GTPase ras homolog gene family, member U/Wnt1 respon-
sive Cdc42 homolog (Rhou/Wrch-1 [number 292, clusters 2
and 7]), which has no detectable intrinsic GTPase activity and
very high nucleotide exchange capacity, leads to an pheno-
type of mature adipocyte [74,75]. Interplay between Rhou
and Tiam1, which might reverse Rhou activity through Rac1
signaling [74], could be a mechanism for regulating cell mor-
phology in adipogenesis.
In summary, the evidence presented above suggests that
reduced replenishment of the cytoskeleton with building
blocks and the strong transcriptional upregulation of modu-
lating proteins, together with the extracellular remodeling,
are responsible for the morphological changes that occur dur-
ing differentiation of 3T3-L1 cells.
Regulation of metabolic networks at the 
transcriptional level via key points of pathways
We next used the molecular atlas to derive novel biological
insights from the global view of molecular processes. We ana-
lyzed transcriptionally regulated genes that are members of
36 different metabolic pathways. Within each pathway, we
considered whether these transcriptionally regulated genes
occupy key positions, such as a position at the pathway start,
which is the typical rate-limiting step where the amount of
enzyme is critical [76], or at some other point of regulation.
We found that such key positions are occupied by transcrip-
tionally regulated targets in 27 pathways (an overview is pro-
vided in Table 1). Those pathways that are strongly
transcriptionally regulated at key points are illustrated in Fig-
ure 5 at the time points 0, 24 and 48 hours, and 14 days. For
additional time points and images with more detailed
information from all investigated pathways, see our website
[20] and Additional data files Additional data file 31 and
Additional data file 32.
In the following discussion we present the evidence for tran-
scriptional regulation at key points for five selected metabolic
pathways. Further information on other pathways can be
found in Additional data files 31, 32, 33, 34, 35, 36, 37, 38 and
on our website [20].
Biosynthesis of the important lipogenic cofactors CoA and NAD(P)+ 
are transcriptionally regulated at their key enzymes
Coenzyme A (CoA) is the carrier of the fatty acid precursor
acetate/malonate [77,78]. Panthotenate kinase 3 (Pank3
[number 140, cluster 6]; about eightfold upregulated) is
responsible for the first and rate-limiting step in converting
panthotenate to CoA [79]. Nicotinamide adenine
dinucleotide phosphate (reduced form; NADPH) is necessary
in reductive reactions for fatty acid synthesis. Pre-B-cell col-
ony-enhancing factor (Visfatin/Pbef1 [number 327, cluster
9]; strongest upregulated in the last three points of the time
course in parallel with the emergence of fat droplets) is the
rate-limiting enzyme in NAD(P)+ biosynthesis [38,80]. For
reduction of NADP+ to NADPH, two major mechanisms are
responsible: the pentose phosphate shunt and the tricarboxy-
late transport system. Hexose-6P dehydrogenase (H6pd
[number 533, cluster 9]; upregulated throughout adipogene-
sis) is the rate limiting enzyme of the pentose phosphate
shunt in the endoplasmic reticulum and provides NADPH to
its lumen [81]. In the cytosolic pendant in the pentose
phosphate shunt, the transaldolase (Taldo1 [number 160,
cluster 3]) is repressed at early stages and is about threefold
upregulated at the end of 3T3-L1 differentiation. This expres-
sion change appears to switch the shunt between ribose-5-
phosphate (for nucleic acid synthesis) and NADPH (for fatty
acid production) synthesis at early and late time points,
respectively. A similar expression profile is observed for the
cytosolic NADP-dependent malic enzyme (Mod1 [number 76,
cluster 3]) and the citrate transporter (Slc25a1/Ctp1 [number
209, cluster 3]). Both are part of the tricarboxylate transport
system through the mitochondrial membrane. Transcription
of the anaplerotic pyruvate carboxylase (Pcx [number 149,
cluster 6]; activated by acetyl-CoA) is increasingly upregu-
lated up to 16-fold toward the final two time points.
Fatty acid modification and assimilation is transcriptionally regulated 
at the rate-limiting steps
The transcriptional expression of stearoyl-CoA desaturase 1
(Scd1 [number 305, cluster 6]), which catalyzes the rate-lim-
iting reaction of monounsaturated fatty acid synthesis and
which is an important marker gene of adipogenesis [82,83], is
downregulated at induction but increases up to 60-fold with
advancing adipogenesis. In contrast to previous reports [82],
we found that the gene for elongation of long-chain fatty acid
(Elovl6 [number 162, cluster 12]) protein, which may be the
rate-limiting enzyme of long chain elongation to stearate
[84], is not overexpressed in differentiated 3T3-L1 cells as in
adipose tissue. Elovl6 appears repressed during the entire
process of adipogenesis in 3T3-L1 cells. Expression of lipo-
protein lipase (Lpl [number 14, cluster 6]), the rate-limiting
enzyme of extracellular triglyceride-rich lipoprotein hydro-
lyzation and triglyceride assimilation [85-87], increases with
time up to 21-fold in differentiated adipocytes.
Transcriptional regulation of triglyceride and fatty acid degradation is 
performed at key points
Adipose triglyceride lipase (Pnpla2/Atgl [number 157, cluster
6]) executes the initial step in triglyceride metabolism [35].
Its expression increases strongly with differentiation progres-
sion. Acyl-CoA dehydrogenases (Acadm/Acadsb [number
153/220, clusters 6 and 9]) [88], the rate-limiting enzymes of
medium, short and branched chain β-oxidation, are strongly
upregulated in the final four time points. In contrast, the acyl-
CoA dehydrogenase (Acadvl) of very long chain fatty acids is
not in the set of distinctly differentially regulated genes, andGenome Biology 2005, 6:R108
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difference in expression might shift the enrichment from
short and medium to long chain fatty acids during adipogen-
sis. Branched chain ketoacid dehydrogenase E1 (Bckdha
[number 193, clusters 3 and 9]) is the rate-limiting enzyme of
leucine, valine, and isoleucine catabolism and is known to be
inhibited by phosphorylation [89]. Its gene shares a similar
expression profile with the Acad genes. The elevated degrada-
tion of amino acids allows conversion to fatty acids through
acetyl-CoA.
Several important nucleotide biosynthetic pathway enzymes follow a 
cell cycle specific expression profile (strongly repressed except 
between 12 and 24 hours)
Phosphoribosylpyrophosphate amidotransferse (Ppat
[number 287, cluster 11]) [90] is rate-limiting for purin pro-
duction. Deoxycytidine kinase (Dck [number 363, cluster 8])
is the rate-limiting enzyme of deoxycytidine (dC),
deoxyguanosine (dG) and deoxyadenosine (dA) phosphoryla-
tion [91-93]. Ribonucleotide reductase M2 (Rrm2 [number
448, cluster 8]) converts ribonucleotides to desoxyribonucle-
otides [94,95]. Additionally, thymidine kinase 1 (Tk1 [number
165, cluster 5]) and dihydrofolate reductase (Dhfr [number
161, cluster 5/8]) play important roles in dT and purin biosyn-
thesis during the cell cycle. In contrast, purin degradation is
about sixfold upregulated between 6 and 72 hours by the rate-
limiting xanthine dehydrogenase (Xdh [number 361, cluster
2]) [96,97]. These findings are in concordance with those of a
previous study [22], which showed that mitotic clonal expan-
sion is a prerequisite for differentiation of 3T3-L1 preadi-
pocytes into adipocytes. After induction of differentiation, the
growth-arrested cells synchronously re-enter the cell cycle
and undergo mitotic clonal expansion, as monitored by
changes in cellular DNA content [22]. In accord with this
experimental evidence, we observed changes in cell cycle
genes, most of which were in clusters 5 and 8 (see our website
[20] and Additional data file 37).
Temporal activation of metabolic pathwaysFigure 5
Temporal activation of metabolic pathways. Summarized is the activation of metabolic pathways at different time points (0 hours, 24 hours, 3 days, and 14 
days) during fat cell differentiation. Color codes are selected according to expression levels of key enzymes in these pathways at distinct time points (red 
= upregulated; green = downregulated).
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whole pathway segments
The synthesis of the early precursor molecule 3-hydroxy-3-
methylglutaryl (HMG)-CoA, which might be also used in
other metabolic pathways, is transcriptionally controlled at
the key enzymes HMG-CoA synthase (Hmgcs1 [number 178,
cluster 4]; repressed except in terminal stages) and HMG-
CoA reductase (Hmgcr [number 619, cluster 12]; always
repressed), which is the rate-limiting enzyme of the choles-
terol and mevalonate pathway [98,99]. After the step of iso-
pentenylpyrophosphate synthesis, cholesterol biosynthesis
genes are coexpressed in cluster 4.
Correspondence between coexpression and 
coregulation
To determine whether coexpressed genes are also coregu-
lated, we analyzed the available promoter sequences of the
780 ESTs. Promoter sequences could be retrieved for 357
genes. Most ESTs are sequenced from the 3' end, and hence it
is easier to retrieve the 3'-UTR. Retrieval of promoters is
more difficult than retrieval of the 3'-UTR because of experi-
mental problems in extracting full-length cDNAs (and hence
transcription start sites) and insufficient computational
methods for identifying beginning of the 5'-UTR. We ana-
lyzed the occurrences of the binding sites of all transcription
factors in vertebrates from the TRANSFAC database. Based
on statistical analyses, among transcription factors with bind-
ing site motifs described in TRANSFAC [100] those listed in
Table 2
Transcription factors that could regulate co-expressed genes in each cluster
Binding factors Over-
represented 
cluster
CS FE Putative target 
genes
Genes in cluster 
with promoter 
in PromoSer 
database
Putative target 
genes of all 
clusters
RORα1 Cluster 1 0.0322 0.0203 10 10 240
ATF Cluster 2 0.0466 0.0481 15 27 133
CRE-BP1 Cluster 2 0.0050 0.0050 19 27 153
HLF Cluster 2 0.0436 0.0452 15 27 132
XBP-1 Cluster 2 0.0378 0.0476 4 27 17
AhR Cluster 2 0.0287 0.0446 3 27 9
Tal-1β/E47 Cluster 3 0.0400 0.0427 9 15 123
v-Maf Cluster 4 0.0432 0.0308 2 12 11
SREBP-1 Cluster 4 0.0494 0.0484 9 12 166
Tal-1β/ITF-2 Cluster 5 0.0145 0.0169 19 46 89
Pbx-1 Cluster 5 0.0323 0.0206 45 46 312
NRF-2 Cluster 5 0.0310 0.0252 41 46 270
Sox-5 Cluster 5 - 0.0490 40 46 268
VBP Cluster 5 0.0345 0.0276 42 46 281
NF-κB (p65) Cluster 6 0.0354 0.0333 13 17 182
CCAAT box Cluster 6 0.0458 0.0287 17 17 288
AP-2 Cluster 6 0.0330 0.0268 15 17 226
E4BP4 Cluster 8 0.0230 0.0243 31 69 113
CCAAT Cluster 8 0.0211 0.0304 5 69 7
VBP Cluster 8 0.0242 0.196 62 69 281
GC box Cluster 9 - 0.0450 44 48 289
RREB-1 Cluster 10 0.0388 0.0435 13 42 65
SRF Cluster 10 0.0221 0.0255 16 42 81
GC box Cluster 10 0.0450 0.0366 39 42 289
Poly A downstream element Cluster 11 0.0335 0.0431 5 13 55
E2 Cluster 12 0.0459 - 14 47 65
Probabilities for over-representation (<0.05) of genes having a predicted transcription factor binding site relative to the total of all clusters. CS, one-
sided χ2 test; FE, one-sided Fisher's exact test.Genome Biology 2005, 6:R108
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tional studies on transcriptional regulation.
One example of a functional transcription factor binding site
is SREBP-1 in cluster 4. A comparison among clusters showed
that cluster 4 has significantly more genes with a SREBP-1
(SRE and E-box motifs [101]) binding site than all other clus-
ters (P = 0.0484, Fisher's exact test; Table 3). Similarly, a
putative SREBP-1 regulatory region is significantly more fre-
quent in the promoters of the genes in cluster 4 compared
with all unique sequences in the PromoSer database (P <
0.0289; PromoSer contains 22,549 promoters of 12,493
unique sequences). For a subset of the genes in cluster 4 with
predicted SREBP-1 binding site (most genes of the cholesterol
biosynthesis pathway), transcriptional regulation with
SREBP-1 has been experimentally proven [102].
Surprisingly, binding sites for the key regulators of adipogen-
esis, namely PPAR and C/EBP, are not significantly over-rep-
resented in any of the promoters of the coexpressed genes.
We generated a novel matrix for PPAR using 22 experimen-
tally verified binding sites from the literature and analyzed
the promoters of the coexpressed genes and all PromoSer
promoters. Again, using this matrix the PPAR binding sites
were not significantly over-represented.
Genomic position of coexpressed genes
Finally, we considered whether coexpressed genes also colo-
calize on the chromosomes. In a broad genomic interval (5
megabases [Mb]) on each mouse chromosome we mapped
the ESTs from each cluster. Unexpectedly, our data do not
support the observation of the highly significant correlation
in the expression and genomic positioning of the genes. A typ-
ical example of mapped ESTs to chromosome 10 is illustrated
in Figure 6, showing that expression levels of colocalized
ESTs are divergent because only two mapped ESTs are mem-
bers of the same cluster.
Additionally, we analyzed the genomic position of 5,205 ESTs
that exhibited significant differentially expression between
time points (P < 0.05; one-way ANOVA). These ESTs were
grouped in 12 clusters, and we then searched for regions with
three or more members in a genomic interval of 500 kilobases
(kb). On average, 7 ± 5% of the ESTs from one cluster were
colocalized. Comprehensive results of this analysis are acces-
sible within the supplementary website [20] and Additional
data files 42, 43, 44, 45.
In summary, these data do not provide evidence that colocal-
ized genes in the genomic sequence are subject to the same
transcriptional regulation (coexpression), as indicated by
examples for different processes in other studies [103].
Table 3
Significance of occurrence of predicted SREBP-1 binding sites in the promoters of co-expressed genes identified by clustering
SREBP-1 Putative target 
genes
Genes in cluster Against total PromoSer database Against total of all clusters
CS FE CS FE
Cluster 1 4 10 0.5000 0.7051 0.5339 0.7644
Cluster 2 11 27 0.5448 0.6892 0.6475 0.7812
Cluster 3 5 16 0.7076 0.8575 0.7697 0.8987
Cluster 4 9 12 0.0290 0.0289 0.0494 0.0484
Cluster 5 16 45 0.7787 0.8570 0.8568 0.9171
Cluster 6 10 20 0.1553 0.1554 0.2278 0.2277
Cluster 7 5 10 0.5000 0.5677 0.5000 0.6423
Cluster 8 31 66 0.2837 0.2827 0.4719 0.4711
Cluster 9 12 42 0.9025 0.9454 0.9414 0.9708
Cluster 10 22 41 0.1635 0.1635 0.2881 0.2877
Cluster 11 8 15 0.3230 0.3204 0.4057 0.4041
Cluster 12 25 45 0.0398 0.0404 0.1014 0.1014
PromoSer 5,456 12,493
Probabilities for over-representation (<0.05) of genes having a predicted SREBP-1 site relative to all unique regulated genes of PromoSer and to the 
total of all clusters. Cluster 4 is the only one with significantly increased occurrence of predicted SREBP-1 binding sites. CS, one-sided χ2 test; FE, 
one-sided Fisher's exact test; SREBP, sterol-regulatory element binding protein.Genome Biology 2005, 6:R108
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The data presented here and the functional annotation con-
siderably extend upon previous microarray analyses of gene
expression in fat cells [8-14] and demonstrate the extent to
which molecular processes can be revealed by global expres-
sion profiling in mammalian cells. Our strategy resulted in a
molecular atlas of fat cell development and provided the first
global view of the underlying biomolecular networks. The
molecular atlas and the dissection of molecular processes
suggest several important biological conclusions.
First, the data support the notion that there are hundreds of
mouse genes involved in adipogenesis that were not previ-
ously linked to this process. Out of the 780 selected genes,
326 were not shared with previous studies [8,9,12], suggest-
ing that our view of this process is far from complete. Using
microarrays enriched with developmental ESTs, we were able
Chromosomal localization analysis for ESTs found to be differentially expressed during fat cell differentiationFigure 6
Chromosomal localization analysis for ESTs found to be differentially expressed during fat cell differentiation. Chromosomal localization analysis for 
chromosome 10 from 780 ESTs shown to be more than two times upregulated or downregulated in a minimum of four time points during adipocyte 
differentiation. (a) Mapped ESTs to chromosome 10. (b) ESTs from cluster 10 mapped to chromosome 10. (c) Relative gene expression levels (log2 ratios) 
at different time points for seven ESTs mapped within a genomic interval of 5 Mb from chromosome 10. EST, expressed sequence tag.
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network but also to map the gene products onto molecular
pathways. The molecular atlas we developed is a unique
resource for deriving testable hypothesis. For example, we
have identified several differentially expressed genes, includ-
ing recently discovered gene products (Pnpla2, Pbef1, Mest)
and transcription factors not previously detected in microar-
ray screens (Zhx3 and Zfp367).
Second, from our global analysis of the potential role of miR-
NAs in fat cell differentiation, we were able to predict poten-
tial target genes for miRNAs in 71% of the 395 genes with a
unique 3'-UTR that were differentially expressed during adi-
pocyte differentiation. The distribution of predicted miRNA
targets indicated that one miRNA may regulate many genes
and that one gene can be regulated by a number of miRNAs.
The function of the potential target genes was diverse and
included transcription factors, enzymes, transmembrane
proteins, and signaling molecules. Genes with the lowest
number of over-represented miRNA motifs were cell cycle
genes (clusters 5 and 8), whereas genes grouped in cluster 9
exhibited the most over-represented miRNA motifs in rela-
tion to the matches in the control set of all available 3'-UTR
sequences. Genes in cluster 9 exhibited high expression val-
ues at time point 0 and may include genes relevant to the
transition from pre-confluent to confluent cells. Genes in
cluster 9 also represent molecular components that are
involved in other cell processes, including extracellular
matrix remodeling, transport, metabolism, and fat cell
development (for example, Foxo1 [44,45]). Genes in other
clusters exhibited varying percentages of over-represented
miRNA motifs and can be associated with diverse biological
processes (Additional data file 6). As an example of functional
miRNA targets, we showed that one signaling molecule of the
ras family is a potential target of miRNAs, which is consistent
with a previous observation in humans, in whom it was shown
that the human RAS oncogene is regulated by the let-7
miRNA. This example indicates that the present analysis pro-
vides promising candidates ranked according to their signifi-
cance of over-representation and the number of different
miRNAs that might regulate these targets in the specific con-
text of adipocyte differentiation. It should be noted that our
analysis included only known miRNAs, suggesting that the
number of target sites can be even higher. This striking obser-
vation could have implications for post-transcriptional regu-
lation of other developmental processes. Microarrays for the
analysis of miRNA expression are becoming available and
future studies will shed light on the role of miRNAs in the
context of cell differentiation.
Third, we were also able to characterize the mechanisms and
gene products involved in the phenotypic changes of pre-adi-
pocytes into mature adipocytes. Although the number of
selected genes in this study was limited, we characterized
gene products for extracellular matrix remodeling and
cytoskeletal changes during adipogenesis. Other molecular
components involved in these processes can be identified by
mapping the characterized gene products onto curated path-
ways [30] and selecting missing candidates for further
focused studies. Notably, most of the cytoskeletal proteins are
coexpressed in cluster 10 and might have a common regula-
tory mechanism. Further computational and experimental
analyses are needed to verify this hypothesis.
In addition to new information about fat cell development,
our comprehensive analysis has provided new general biolog-
ical insights that could only be derived from such a global
analysis. First, we were able to examine at what points meta-
bolic pathways were regulated. The global view of biological
processes and networks derived from expression profiles
showed that the metabolic networks are transcriptionally reg-
ulated at key points, usually the rate-limiting steps. This was
the case in 27 out of the 36 metabolic pathways analyzed in
this study. During the development of mature adipocytes
from pre-adipocytes, distinct metabolic pathways are acti-
vated and deactivated by this molecular control mechanism.
For example, at the beginning nucleotide metabolism is acti-
vated because the cells undergo clonal expansion and one
round of the cell cycle (see out website [20] and Additional
data file 37). At the end of development, major metabolic
pathways for lipid metabolism are upregulated, including β-
cell oxidation and fatty acid synthesis (Figure 5). Cell devel-
opment is a dramatic process in which the cell undergoes bio-
chemical and morphological changes. In our study signals at
every time point could be detected from more than 14,000
ESTs. Thus, regulating metabolic networks at key points rep-
resents an energy efficient way to control cellular processes.
Metabolic networks might be activated/inactivated in a simi-
lar manner in other types of cellular differentiation, such as
myogenesis or osteogenesis. It is intriguing to speculate that
signaling networks are also transcriptionally regulated at key
points. However, as opposed to the metabolic networks, it is
difficult to verify this hypothesis because the key points are
not clearly identifiable due to both the interwoven nature and
the partial incompleteness of the signaling pathways.
A second general biological insight derived from our global
analysis is that we found that many genes were upregulated
by well known transcription factors that nevertheless lacked
anything resembling the established upstream promoter con-
sensus sites. Over-represented binding sites for key regula-
tors such as PPAR and C/EBP were not detectable with the
TRANSFAC matrices. Even the use of a matrix based on all
currently available experimentally validated sequences, such
as PPAR, did not result in a significant hit. Hence, only few
sequences contain this motif in their promoters. These results
demonstrate either that much more sophisticated methods
must be developed or that there are many cases where the
current methods do not perform well because other aspects
such as chromatin determine the recognition site.Genome Biology 2005, 6:R108
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analysis is the finding that coexpressed genes in fat cell devel-
opment are not clustered in the genome. Previous studies
identified a number of such cases in a range of organisms,
including yeast [104], worms [105], and flies [106]. This
observation of significant correlation in the expression and
genomic position of genes was recently reported in the mouse
[103]. In the present study we could not identify groups of
genes with similar expression profiles, for instance within the
same cluster within 5 Mb regions on the chromosomes. Our
results suggest that such clustering may not be as widespread
as may be presumed by extrapolating from previous studies.
However, coexpressed genes could have distant locations and
still be spatially colocalized due to DNA looping and banding,
as was recently shown in a microscopy study [107]. A higher
order chromatin structure of the mammalian transcriptome
is an emerging concept [108], and new methods are required
to examine the correlation between gene activity and spatial
positioning.
The biological insights gained in this study were only possible
with in-depth bioinformatics analyses based on segment and
domain predictions. Distribution of GO terms permits a first
view of the biological processes, molecular functions, and cel-
lular components. However, in our work more than 40% of
the ESTs could not be assigned to GO terms. Moreover,
detailed information about the specific functions cannot be
extracted. For example, the GO term 'DNA binding' could be
specified by 'zinc-finger domain binding protein' only by in-
depth analyses. Hence, de novo functional annotation of ESTs
using integrated prediction tools and subsequent curation of
the results based on the available literature is not only neces-
sary to complete the annotation process but also to reveal the
actual biological processes and metabolic networks. Although
the number of protein sequences to which a GO term can be
assigned is steadily increasing, specific and detailed annota-
tion is only possible with de novo functional annotation.
Conclusion
In the present study we demonstrate that, despite the limita-
tions due to mRNA abundance (many thousands of genes are
never transcribed above threshold) and insufficient sensitiv-
ity, large-scale gene expression profiling in conjunction with
sophisticated bioinformatics analyses can provide not only a
list of novel players in a particular setting but also a global
view on biological processes and molecular networks.
Materials and methods
cDNA microarrays
The microarray developed here contains 27,648 spots with
mouse cDNA clones representing 16,016 different genes (Uni-
Gene clusters). These include developmental clones (the 15 K
NIA cDNA clone set from National Institute of Aging, US
National Institutes of Health) and the 11 K clones from
different brain regions in the mouse (Brain Molecular Anat-
omy Project [BMAP]). Moreover, 627 clones for adipose-
related genes were selected using the TIGR Mouse Gene
Index Build 5.0 [19]. These cDNA clones were obtained from
the IMAGE consortium (Research Genetics, Huntsville, AL,
USA). The inserts of the NIA and BMAP clones were sequence
verified (insert size about 1-1.5 kb). All PCR products were
purified using size exclusion vacuum filter plates (Millipore,
Billerica, MA, USA) and spotted onto amino-silanated glass
slides (UltraGAPS II; Corning, Corning, NY, USA) in a 4 × 12
print tip group pattern. As spotting buffer 50% dimethyl sul-
foxide was used. Negative controls (genomic DNA, genes
from Arabidopsis thaliana, and dimethyl sulfoxide) and pos-
itive controls (Cot1-DNA and salmon sperm DNA) were
included in each of the 48 blocks. Samples were bound to the
slides by ultraviolet cross-linking at 200 mJ in a Stratalinker
(Stratagene, La Jolla, CA, USA).
Cell culture
3T3-L1 cells (American Type Culture Collection number CL-
173) were grown in 100 mm diameter dishes in Dulbecco's
modified Eagle's medium supplemented with 10% fetal
bovine serum, 100 units/ml penicillin, 100 µg/ml streptomy-
cin, and 2 mmol/l L-glutamine in an atmosphere of 5% car-
bon dioxide at 37°C. Two days after reaching confluence (day
0), cells were induced to differentiate with a two-day incuba-
tion of a hormone cocktail [109,110] (100 µmol/l 3-iso-butyl-
1-methylxanthine, 0.25 µmol/l dexamethasone, 1 µg/ml insu-
lin, 0.16 µmol/l pantothenic acid, and 3.2 µmol/l biotin)
added to the standard medium described above. After 48
hours (day 2), cells were cultured in the standard medium in
the presence of 1 µg/ml insulin, 0.16 µmol/l pantothenic acid,
and 3.2 µmol/l biotin until day 14. Nutrition media were
changed every second day.
Three independent cell culture experiments were performed.
Cells were harvested and total RNA was isolated at the pre-
confluent stage and at eight time points (0, 6, 12 and 24
hours, and 3, 4, 7 and 14 days) with TRIzol reagent
(Invitrogen-Life Technologies; Carlsbad, CA, USA) [111]. For
each independent experiment, RNA was pooled from three
different culture dishes for each time point and from 24
dishes at the preconfluent stage used as reference. The quality
of the RNA was checked using Agilent 2100 Bioanalyzer RNA
assays (Agilent Technologies, Palo Alto, CA, USA) by inspec-
tion of the 28S and 18S ribosomal RNA intensity peaks.
Labeling and hybridization
The labeling and hybridization procedures used were based
on those developed at the Institute for Genomic Research
[112] and detailed protocols can be viewed on the supplemen-
tary website [20]. Briefly, 20 µg total RNA from each time
point was reverse transcribed in cDNA and indirectly labeled
with Cy5 and 20 µg RNA from the preconfluent stage (refer-
ence) was indirectly labeled with Cy3, respectively. This pro-
cedure was repeated with reversed dye assignment. SlidesGenome Biology 2005, 6:R108
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µg mouse Cot1 DNA and 10 µg poly(A) DNA was added to the
labeled cDNA samples and pair-wise cohybridized onto the
slide for 20 hours at 42°C. Following washing, slides were
scanned with a GenePix 4000B microarray scanner (Axon
Instruments, Sunnyvale, CA, USA) at 10 µm resolution. Iden-
tical photo multiplier voltage settings were used in the scan-
ning of the corresponding dye-swapped hybridized slides.
The resulting TIFF images were analyzed with GenePix Pro
4.1 software (Axon Instruments).
Data preprocessing and normalization
Data were filtered for low intensity, inhomogeneity, and sat-
urated spots. To obtain expression values for the saturated
spots, slides were scanned a second time with lower photom-
ultiplier tube settings and reanalyzed. All spots of both chan-
nels were background corrected (by subtraction of the local
background). Different sources of systematic (sample, array,
dye, and gene effects) and random errors can be associated
with microarray experiments [113]. Nonbiological variation
must be removed from the measurement values and the ran-
dom error can be minimized by normalization [114,115]. In
the present study, gene-wise dye swap normalization was
applied. Genes exhibiting substantial differences in intensity
ratios between technical replicates were excluded from fur-
ther analysis based on a two standard deviation cutoff. The
resulting ratios were log2 transformed and averaged over
three independent experiments. The expression profiles were
not rescaled in order to identify genes with high expression
values. All experimental parameters, images, and raw and
transformed data were uploaded to the microarray database
MARS [116] and submitted via MAGE-ML export to a public
repository (ArrayExpress [117], accession numbers A-MARS-
1 and E-MARS-2). Differentially expressed genes were first
identified using one-way ANOVA (P < 0.05). They were then
subjected to a more stringent criterion; specifically, we con-
sidered only those genes with a complete temporal profile
that were more than twofold upregulated or downregulated at
a minimum of four time points. The twofold cutoff for differ-
entially expressed genes was estimated by applying the signif-
icance analyses of microarrays method [118] to the biological
replicates and assuming false discovery rate of 5%. In order to
capture the dynamics of various processes, only ESTs differ-
entially expressed in at least half of the time points were
selected. Data preprocessing was performed with ArrayNorm
[119].
Real-time RT-PCR
Microarray expression results were confirmed with RT-PCR.
cDNA was synthesized from 2.5 µg total RNA in 20 µl using
random hexamers and SuperScript III reverse transcriptase
(Invitrogen, Carlsbad, CA, USA). The design of LUX™ prim-
ers for Pparg, Lpl, Myc, Dec, Ccna2, and Klf9 was done using
the Invitrogen web service (for sequences, see Additional data
file 9 and our website [20]). Quantitative RT-PCR analyses
for these genes were performed starting with 50 ng reverse
transcribed total RNA, with 0.5× Platinum Quantitative PCR
SuperMix-UDG (Invitrogen, Carlsbad, CA, USA), with a ROX
reference dye, and with a 200 nmol/l concentration of both
LUX™ labeled sense and antisense primers (Invitrogen,
Carlsbad, CA, USA) in a 25 µl reaction on an ABI PRISM 7000
sequence detection system (Applied Biosystems, Foster City,
CA, USA). To measure PCR efficiency, serial dilutions of
reverse transcribed RNA (0.24 pg to 23.8 ng) were amplified.
Ribosomal 18S RNA amplifications were used to account for
variability in the initial quantities of cDNA. The relative quan-
tification for any given gene with respect to the calibrator
(preconfluent stage) was determined using the ∆∆Ct method
and compared with the normalized ratios resulting from
microarray experiments.
Clustering and gene ontology classification
Common unsupervised clustering algorithms [120] were used
for clustering expression profiling of 780 selected ESTs,
according to the log ratios from all time points. Using hierar-
chical clustering the boundaries of the clusters were not
clearly separable and required arbitrary determination of the
branching point of the tree, whereas the results of the cluster-
ing using self-organized maps led to clusters with highly
divergent number of ESTs (between 3 and 242). We have
therefore used the k means algorithm [121] and Euclidean
distance. The number of clusters was varied from k = 1 to k =
20, and predictive power was analyzed with the figure of
merit [122]. Subsequently, k = 12 was found to be optimal. To
evaluate the results of the k means clustering, principal com-
ponent analysis [123] was applied and exhibited low intrac-
luster distances and high intercluster dissimilarities. GO
terms and GO numbers for molecular function, biological
process, and cellular components were derived from the Gene
Ontology database (Gene Ontology Consortium) using the
GenPept/RefSeq accession numbers for annotated proteins
encoded by selected genes (ESTs). All cluster analyses and
visualizations were performed using Genesis [124].
De novo annotation of ESTs
For each of the 780 selected EST sequences, we attempted to
find the corresponding protein sequence. Megablast [125]
searches (word length w = 70, percentage identity p = 95%)
against nucleotide databases (in the succession of RefSeq
[126,127], FANTOM [128], UniGene [129], nr GenBank, and
TIGR Mouse Gene Index [19] until a gene hit was found) were
carried out. For the ESTs still remaining without gene assign-
ment, new Megablast searches were conducted with the larg-
est compilation of RefSeq (including the provisional and
automatically generated records [126,127]). If an EST
remained unassigned, then the whole procedure was repeated
with blastn [130]. In addition, a blastn search against the
ENSEMBL mouse genome [131] was performed, and ESTs
with long stretches (>100 base pairs) of unspecified nucle-
otides (N) were excluded.Genome Biology 2005, 6:R108
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prediction tools that are integrated into ANNOTATOR, a
novel protein sequence analysis system [132]: compositional
bias (SAPS [133], Xnu, Cast [134], GlobPlot 1.2 [135]); low
complexity regions (SEG [136]); known sequence domains
(Pfam [137], Smart [138], Prosite and Prosite pattern [139]
with HMMER, RPS-BLAST [140], IMPALA [141], PROSITE-
Profile [139]); transmembrane domains (HMMTOP 2.0
[142], TOPPRED [143], DAS-TMfilter [144], SAPS [133]);
secondary structures (impCOIL [145], Predator [146], SSCP
[147,148]); targeting signals (SIGCLEAVE [149], SignalP-3.0
[150], PTS1 [151]); post-translational modifications (big-PI
[152], NMT [153], Prenylation); a series of small sequence
motifs (ELM, Prosite patterns [139], BioMotif-IMPlibrary);
and homology searches with NCBI blast [130]. Further infor-
mation was retrieved from the databases of Mouse Genome
Informatics [154] and LocusLink [126].
Promoter analysis
The promoters were retrieved from PromoSer database [155]
through the gene accession number. PromoSer contains
22,549 promoters for 12,493 unique genes. Nucleotides from
2,000 upstream and 100 downstream of the transcription
start site were obtained. With an implementation of the Mat-
Inspector algorithm [156], the Transfac matrices [100] were
checked for binding sites in the promoter regions with a
threshold for matrix similarity of 0.85. We counted the
number of those gene sequences that were found to carry a
predicted transcription factor binding site. As a reference set
all unique genes of the PromoSer were reanalyzed. A one-
sided χ2 test and a one-sided Fisher's exact test (to improve
the statistics for view counts) were performed with the statis-
tical tool R [157] to determine the clusters with a higher affin-
ity for a transcription factor.
Identification of miRNA target sites in 3'-UTR
All available 3'-UTR sequences (21,396) for mouse genes were
derived with EnsMart [158], using Ensembl gene build for the
NCBI m33 mouse assembly. 3'-UTRs for unique genes repre-
sented by the 780 selected ESTs were extracted using
Ensembl transcript ID. A total of 234 mouse miRNA
sequences were derived from the Rfam database [159]. The 3'-
UTR sequences were searched for antisense matches to the
designated seed region of each miRNA (bases 1-8, 2-8, 1-9,
and 2-9 starting from the 5' end). Significantly over-repre-
sented miRNA motifs in each cluster in comparison with the
remaining motifs in the whole 3'-UTR sequence set were
determined using the one-sided Fisher's exact test (signifi-
cance level: P < 0.05) and miRNA targets of all clusters were
analyzed for significantly over-represented miRNAs.
Chromosomal localization analysis
RefSeq sequences for 780 selected ESTs, shown to be more
than two times upregulated or downregulated in a minimum
of four time points during adipocyte differentiation and clus-
tered according their expression profiles, were mapped onto
the chromosomes from the NCBI Mus musculus genome
(build 33) using ChromoMapper 2.1.0 software [160] based
on MegaBlast with the following parameters: 99% identity
cutoff, word size 32, and E-value (0.001). Colocalized
sequences of all selected ESTs and from each of the 12 clusters
within a 5 Mb genomic interval were identified. Within the
5Mb genomic intervals of each chromosome with the highest
density of mapped ESTs, relative gene expression levels (log2
ratios) of these ESTs at different time points were related to
the genomic localization.
Additional data files
The following additional data are provided with the online
version of this article: A spot map for the array design (Addi-
tional data file 1); a fasta file containing the EST sequences
used for the array (Additional data file 2); an Excel file con-
taining expression values for the 780 selected ESTs (Addi-
tional data file 3); an Excel file containing expression values
for the 5205 ESTs filtered with ANOVA (Additional data file
4); GenePix result files containing raw data (Additional data
file 5); images showing the distribution of gene ontology
(Additional data file 6); a table listing relevant proteins (Addi-
tional data file 7); a fasta file containing sequences of the rel-
evant proteins (Additional data file 8); a pdf file containing
real-time RT-PCR data (Additional data file 9); a table includ-
ing statistical analysis of independent experiments (Addi-
tional data file 10); figure showing a comparison with
GeneAtlas (Additional data file 11); a table including expres-
sion levels from the present study and GeneAtlas (Additional
data file 12); figure showing a comparison with the data set
reported by Soukas and coworkers [8]Additional data file 13);
figure showing a comparison with the data set reported by
Ross and coworkers [9] (Additional data file 14); figure show-
ing a comparison with the data set reported by Burton and
coworkers [12] (Additional data file 15); a table including
ESTs unique to the present study (Additional data file 16); a
figure showing genes with miRNA motifs in 3'-UTR (Addi-
tional data file 17); a figure illustrating the significant over-
representation of miRNA motifs in the 3'-UTR of genes in
each cluster (Additional data file 18); figures showing the sig-
nificant over-representation of miRNA motifs in the 3'-UTR
from genes in each cluster (Additional data files 19, 20, 21, 22,
23, 24, 25, 26, 27, 28, 29); a table including over-represented
miRNA motifs in the 3'-UTR from genes in the set of 780
selected ESTs (Additional data file 30); text describing regu-
lation of metabolic pathways (Additional data file 31); figure
showing regulation of metabolic pathways by key points
(Additional data file 32); figure showing the cellular localiza-
tion of gene products involved in metabolism and their gene
expression at different time points (Additional data file 33);
figure showing the cellular localization of gene products
involved in other biological processes and their gene expres-
sion at different time points (Additional data file 30); text
describing signaling networks (Additional data file 35); text
file describing extracellular matrix remodeling and cytoskele-Genome Biology 2005, 6:R108
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cell cycle processes (Additional data file 37); figure showing
the cholesterol pathway (Additional data file 38); a list of
experimental verified binding site for PPAR:RXR and the
derived position weight matrix (Additional data file 39); text
file containing TRANSFAC matrices for vertebrates (Addi-
tional data file 40); a file showing the promoter sequences in
fasta format (Additional data file 41); figure showing cluster-
wise mapping of 780 ESTs to all chromosomes (Additional
data file 42); figure showing expression of colocalized ESTs
for each cluster (Additional data file 43); an Excel file showing
a statistical analysis of colocalized ESTs for 780 selected ESTs
(Additional data file 44); and an Excel file showing a statisti-
cal analysis of colocalized ESTs for 5,502 ANOVA selected
ESTs (Additional data file 45).
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